Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-14: Form 6-K; Period of report 2026-09-14; Description 6-K; Document form6k_091426.htm.
- 2026-08-31: Form 6-K; Period of report 2026-08-28; Description 6-K; Document form6k_082826.htm.
- 2026-08-06: Form 6-K; Period of report 2026-08-05; Description 6-K; Document form6k_080526.htm.
- 2026-07-30: Form 6-K; Period of report 2026-07-30; Description 6-K; Document form6k_073026.htm.